![Zhan Chao Liang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Zhan Chao Liang
Chief Investment Officer bei Shanghai Med-Fine Asset Management Co. Ltd.
Profil
Zhan Chao Liang is currently the Director at Beijing Mabworks Biotech Co., Ltd.
and the Chief Investment Officer & Partner at Shanghai Med-Fine Asset Management Co. Ltd.
He completed his undergraduate degree from Hlj August First Land Reclamation University in 2008 and his graduate degree from the Academy of Military Medical Sciences in 2011.
Aktive Positionen von Zhan Chao Liang
Unternehmen | Position | Beginn |
---|---|---|
Beijing Mabworks Biotech Co., Ltd.
![]() Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | Direktor/Vorstandsmitglied | 01.05.2016 |
Shanghai Med-Fine Asset Management Co. Ltd. | Chief Investment Officer | 01.04.2015 |
Ausbildung von Zhan Chao Liang
Hlj August First Land Reclamation University | Undergraduate Degree |
Academy of Military Medical Sciences | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Beijing Mabworks Biotech Co., Ltd.
![]() Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | Health Technology |
Shanghai Med-Fine Asset Management Co. Ltd. |